Treatment of Subacute Thyroiditis with Palpitations and Tachycardia in Transient Thyrotoxicosis
Subacute thyroiditis can enter a transient thyrotoxic phase in which excess circulating thyroid hormone drives cardiovascular symptoms. When palpitations and tachycardia are prominent presenting features, a specific therapeutic strategy is indicated to bring the cardiovascular picture under control.
Clinical Scenario
Subacute thyroiditis with transient thyrotoxicosis presenting with symptoms including palpitations and tachycardia. Patients in this phase may also exhibit a broader spectrum of thyrotoxic manifestations alongside the predominant cardiovascular symptoms.
Treatment Approach (partial overview)
Management targets the cardiovascular manifestations directly. A specific class of agents is used for symptomatic relief of heart-rate and blood-pressure elevation — acting on the cardiovascular system rather than on thyroid hormone production or secretion itself. The complete regimen, including selection criteria and monitoring guidance, is available via the structured protocol.
Clinical Goals
Primary targets: control of tachycardia and hypertension during the thyrotoxic phase.
References
- Clinically, patients may display a range of symptoms commonly associated with thyrotoxicosis, such as palpitations, anorexia, diarrhea, excessive sweating, insomnia, anxiety, tremors, and agitation.
- Beta-blockers are commonly used to control symptoms such as tachycardia and hypertension, offering symptomatic relief without interfering with thyroid hormone levels.
DOI: 10.3390/jcm14093233
View source ↗